Kenvue (KVUE) Competitors

Kenvue (NYSE:KVUE) and Johnson & Johnson (NYSE:JNJ) are related large-cap companies, but which is the better business? We will compare the two companies based on the strength of their risk, analyst recommendations, media sentiment, earnings, profitability, institutional ownership, dividends and valuation.

Which has more volatility & risk, KVUE or JNJ?

Kenvue has a beta of 0.83, indicating that its stock price is 17% less volatile than the S&P 500. Comparatively, Johnson & Johnson has a beta of 0.41, indicating that its stock price is 59% less volatile than the S&P 500.

Do institutionals and insiders hold more shares of KVUE or JNJ?

97.6% of Kenvue shares are held by institutional investors. Comparatively, 69.6% of Johnson & Johnson shares are held by institutional investors. 1.7% of Kenvue shares are held by insiders. Comparatively, 0.2% of Johnson & Johnson shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Is KVUE or JNJ more profitable?

Johnson & Johnson has a net margin of 25.00% compared to Kenvue's net margin of 6.90%. Johnson & Johnson's return on equity of 32.49% beat Kenvue's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Kenvue	6.90%	20.87%	8.04%
Johnson & Johnson	25.00%	32.49%	13.00%

Is KVUE or JNJ a better dividend stock?

Kenvue pays an annual dividend of $0.82 per share and has a dividend yield of 3.8%. Johnson & Johnson pays an annual dividend of $5.20 per share and has a dividend yield of 3.0%. Kenvue pays out 149.1% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Johnson & Johnson pays out 55.6% of its earnings in the form of a dividend. Kenvue has raised its dividend for 1 consecutive years and Johnson & Johnson has raised its dividend for 64 consecutive years.

Do analysts recommend KVUE or JNJ?

Kenvue currently has a consensus price target of $24.79, indicating a potential upside of 13.90%. Johnson & Johnson has a consensus price target of $174.50, indicating a potential upside of 1.80%. Given Kenvue's higher probable upside, research analysts clearly believe Kenvue is more favorable than Johnson & Johnson.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Kenvue	0 Sell rating(s)	7 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.42
Johnson & Johnson	0 Sell rating(s)	9 Hold rating(s)	9 Buy rating(s)	2 Strong Buy rating(s)	2.65

Does the media prefer KVUE or JNJ?

In the previous week, Johnson & Johnson had 65 more articles in the media than Kenvue. MarketBeat recorded 96 mentions for Johnson & Johnson and 31 mentions for Kenvue. Johnson & Johnson's average media sentiment score of 1.44 beat Kenvue's score of 1.05 indicating that Johnson & Johnson is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Kenvue	18 Very Positive mention(s)	3 Positive mention(s)	5 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Positive
Johnson & Johnson	87 Very Positive mention(s)	1 Positive mention(s)	6 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Which has better earnings & valuation, KVUE or JNJ?

Johnson & Johnson has higher revenue and earnings than Kenvue. Johnson & Johnson is trading at a lower price-to-earnings ratio than Kenvue, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Kenvue	$15.46B	2.70	$1.03B	$0.55	39.57
Johnson & Johnson	$88.82B	4.65	$14.07B	$9.35	18.33

Summary

Johnson & Johnson beats Kenvue on 14 of the 20 factors compared between the two stocks.